Reconfigurable circuit and decoder therefor
    1.
    发明授权
    Reconfigurable circuit and decoder therefor 有权
    可重构电路及解码器

    公开(公告)号:US09110133B2

    公开(公告)日:2015-08-18

    申请号:US14277053

    申请日:2014-05-14

    摘要: A digital decoder, used in a reconfigurable circuit, for decoding digital pulses includes a phase indicator module having inputs coupled to a reference pulse input and a data pulse input. The phase indicator module has timing information outputs that provide logic values indicative of rising and falling edges of pulses occurring on the reference pulse input and the data pulse input. A phase decoder module has inputs coupled to the timing information outputs, and outputs decoded binary data values. In operation, the phase decoder module compares at least two of the logic values at the timing information outputs with a signal representative leading and trailing edges of a pulse applied to one of the phase inputs to determine a pulse arrival order sequence on the phase inputs and thereby provide the decoded binary data values.

    摘要翻译: 在可重构电路中用于解码数字脉冲的数字解码器包括具有耦合到参考脉冲输入和数据脉冲输入的输入的相位指示器模块。 相位指示器模块具有提供指示在参考脉冲输入和数据脉冲输入上出现的脉冲的上升沿和下降沿的逻辑值的定时信息输出。 相位解码器模块具有耦合到定时信息输出的输入,并且输出解码的二进制数据值。 在操作中,相位解码器模块将定时信息输出处的至少两个逻辑值与施加到相位输入之一的脉冲的代表性的前沿和后沿的信号进行比较,以确定相位输入上的脉冲到达顺序序列, 从而提供解码的二进制数据值。

    RECONFIGURABLE CIRCUIT AND DECODER THEREFOR
    2.
    发明申请
    RECONFIGURABLE CIRCUIT AND DECODER THEREFOR 有权
    可重构电路及其解码器

    公开(公告)号:US20150048863A1

    公开(公告)日:2015-02-19

    申请号:US14277053

    申请日:2014-05-14

    IPC分类号: G01R31/3177

    摘要: A digital decoder, used in a reconfigurable circuit, for decoding digital pulses includes a phase indicator module having inputs coupled to a reference pulse input and a data pulse input. The phase indicator module has timing information outputs that provide logic values indicative of rising and falling edges of pulses occurring on the reference pulse input and the data pulse input. A phase decoder module has inputs coupled to the timing information outputs, and outputs decoded binary data values. In operation, the phase decoder module compares at least two of the logic values at the timing information outputs with a signal representative leading and trailing edges of a pulse applied to one of the phase inputs to determine a pulse arrival order sequence on the phase inputs and thereby provide the decoded binary data values.

    摘要翻译: 在可重构电路中用于解码数字脉冲的数字解码器包括具有耦合到参考脉冲输入和数据脉冲输入的输入的相位指示器模块。 相位指示器模块具有提供指示在参考脉冲输入和数据脉冲输入上出现的脉冲的上升沿和下降沿的逻辑值的定时信息输出。 相位解码器模块具有耦合到定时信息输出的输入,并且输出解码的二进制数据值。 在操作中,相位解码器模块将定时信息输出处的至少两个逻辑值与施加到相位输入之一的脉冲的代表性的前沿和后沿的信号进行比较,以确定相位输入上的脉冲到达顺序序列, 从而提供解码的二进制数据值。

    Integrated circuit with increased fault coverage
    3.
    发明授权
    Integrated circuit with increased fault coverage 有权
    具有增加故障覆盖的集成电路

    公开(公告)号:US09297855B1

    公开(公告)日:2016-03-29

    申请号:US14559899

    申请日:2014-12-03

    摘要: An electronic design automation (EDA) tool for increasing the fault coverage of an integrated circuit (IC) design includes a processor that inserts at least one XOR gate, an AND gate, an OR gate and a multiplexer between observation test points and an existing first scan flip-flop of the IC design. The XOR gate provides an observation test signal to the first scan flip-flop by way of the AND gate, the OR gate, and the multiplexer such that the observation test signal covers the presence of faults at the observation test points. The first scan flip-flop outputs a data input signal, a set of test patterns, and a first set of test signals based on the observation test signal to indicate whether the IC design is faulty or not. A testable IC that can be structurally tested is fabricated using the IC design.

    摘要翻译: 用于增加集成电路(IC)设计的故障覆盖的电子设计自动化(EDA)工具包括处理器,其在观察测试点和现有的第一个(或第一)之间插入至少一个异或门,与门,或门和多路复用器 扫描触发器的IC设计。 异或门通过与门,或门和多路复用器向第一扫描触发器提供观测测试信号,使得观察测试信号覆盖观察测试点处的故障的存在。 第一扫描触发器基于观察测试信号输出数据输入信号,一组测试图案和第一组测试信号,以指示IC设计是否有故障。 使用IC设计制造可以结构测试的可测IC。

    Wire configuration and method of making for an implantable medical apparatus
    5.
    发明授权
    Wire configuration and method of making for an implantable medical apparatus 有权
    电线配置和可植入医疗器械的制造方法

    公开(公告)号:US08639352B2

    公开(公告)日:2014-01-28

    申请号:US12419082

    申请日:2009-04-06

    IPC分类号: A61N1/04

    摘要: A filar includes an inner conductive core that is formed of a low-resistivity material such as silver having a resistivity of less than 20 μΩ per centimeter. A conductive coil is provided around the core to form a filar. This coil is formed of a biocompatible alloy or super alloy having an ultimate tensile strength (UTS) of between 150 kilo pounds per square inch (ksi) and 280 ksi at room temperature. Examples of such alloys include CoCrMo, CoFeCrMo, and CoFeNiCrMo. In one specific embodiment, the alloy is MP35N (CoNiCrMo), which may be low-titanium (“low-ti”) MP35N. One or more such filars may be included within a wire. This wire may be carried by an implantable medical apparatus such as a lead, lead extension, or catheter. The wire may electrically couple elements such as connector electrodes to conducting electrodes or sensors.

    摘要翻译: 丝状物包括由诸如银的低电阻率材料形成的内导电芯,其电阻率小于每平方厘米20微米。 在芯周围设置导电线圈以形成丝状体。 该线圈由在室温下具有150千磅/平方英寸(ksi)和280ksi之间的极限拉伸强度(UTS)的生物相容性合金或超级合金形成。 这种合金的实例包括CoCrMo,CoFeCrMo和CoFeNiCrMo。 在一个具体实施方案中,合金是MP35N(CoNiCrMo),其可以是低钛(“低钛”)MP35N。 一根或多根这样的丝状物可以包括在线内。 该线可以由诸如铅,引线延伸或导管的可植入医疗设备携带。 导线可以将诸如连接器电极的元件电耦合到导电电极或传感器。

    Recombinant human interferon-like proteins
    6.
    发明授权
    Recombinant human interferon-like proteins 有权
    重组人干扰素样蛋白

    公开(公告)号:US08425895B2

    公开(公告)日:2013-04-23

    申请号:US12665682

    申请日:2007-06-22

    摘要: This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human interferon alpha 2b (HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID NO: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon therapy, such as viral diseases and cancer.

    摘要翻译: 本申请涉及重组人类干扰素样蛋白。 在一个实施方案中,与天然存在的人干扰素α2b(HuIFN-α2b)相比,描述了通过基因改组技术产生的重组蛋白质具有增强的抗病毒和抗增殖活性。 本发明包括编码蛋白质的多核苷酸和包含多核苷酸的重组载体和宿主细胞。 优选地,多核苷酸选自各自具有与SEQ ID:No.1至少93%相同的序列的多核苷酸,并且所述蛋白质选自蛋白质组,其各自具有与SEQ ID NO:至少85%相同的氨基酸序列 包含蛋白质的蛋白质和组合物可用于治疗对干扰素治疗(例如病毒性疾病和癌症)有反应的病症。

    Serializer with odd gearing ratio
    7.
    发明授权
    Serializer with odd gearing ratio 有权
    具有奇数传动比的串行器

    公开(公告)号:US08274412B1

    公开(公告)日:2012-09-25

    申请号:US12987393

    申请日:2011-01-10

    IPC分类号: H03M9/00

    CPC分类号: H03M9/00

    摘要: In certain embodiments of the invention, a serializer has (a) an initial, transfer stage that transfers incoming parallel data from a relatively slow timing domain to a relatively fast timing domain and (b) a final, serializing stage that converts the parallel data into serialized data. Between the transfer stage and the serializing stage is an update stage that (i) buffers data between the initial and final stages and (ii) can be used to toggle the serializer between an N−1 operating mode (that serializes (N−1) bits of parallel data) and an N+1 operating mode (that serializes (N+1) bits of parallel data) to achieve a net N:1 gearing ratio where N is an odd integer. The serializer can be configurable to support other gearing ratios as well.

    摘要翻译: 在本发明的某些实施例中,串行器具有(a)初始传送级,其将输入的并行数据从相对较慢的定时域传送到相对较快的定时域,以及(b)将并行数据转换成 序列化数据。 在转移阶段和序列化阶段之间是更新阶段,(i)缓冲初始阶段和最后阶段之间的数据,(ii)可用于在N-1操作模式(序列化(N-1) 并行数据的位)和N + 1工作模式(串行化并行数据的(N + 1)位),以实现净N:1的传动比,其中N是奇整数。 串行器可以配置为支持其他传动比。

    Entity-based business intelligence
    8.
    发明授权
    Entity-based business intelligence 有权
    基于实体的商业智能

    公开(公告)号:US07792856B2

    公开(公告)日:2010-09-07

    申请号:US11771668

    申请日:2007-06-29

    IPC分类号: G06F17/30 G06F7/00

    CPC分类号: G06F17/30592 G06F17/30489

    摘要: A method is disclosed for conducting a query to transform data in a pre-existing database, the method comprising: collecting database information from the pre-existing database, the database information including inconsistent dimensional tables and fact tables; running an entity discovery process on the inconsistent dimensional tables and the fact tables to produce entity mapping tables; using the entity mapping tables to resolve the inconsistent dimensional tables into resolved dimensional tables; and running the query on a resolved database to obtain a query result, the resolved database including the resolved dimensional table.

    摘要翻译: 公开了一种用于进行在预先存在的数据库中转换数据的查询的方法,所述方法包括:从预先存在的数据库收集数据库信息,所述数据库信息包括不一致的维度表和事实表; 对不一致的维度表和事实表运行实体发现过程以生成实体映射表; 使用实体映射表将不一致的维度表解析为已解析的维度表; 并在解析的数据库上运行查询以获取查询结果,解析的数据库包括已解析的维度表。

    Recombinant human interferon-like proteins
    9.
    发明授权
    Recombinant human interferon-like proteins 有权
    重组人干扰素样蛋白

    公开(公告)号:US07625555B2

    公开(公告)日:2009-12-01

    申请号:US11764786

    申请日:2007-06-18

    摘要: This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human interferon alpha 2b (HuIFN-α2b). The invention encompasses a polynucleotide encoding the protein and recombinant vectors and host cells comprising the polynucleotide. Preferably the polynucleotide is selected from the group of polynucleotides each having a sequence at least 93% identical to SEQ ID: No. 1 and the protein is selected from the group of proteins each having an amino acid sequence at least 85% identical to SEQ ID No: 2. The proteins and compositions comprising the proteins can be used for treatment of conditions responsive to interferon therapy, such as viral diseases and cancer.

    摘要翻译: 本申请涉及重组人类干扰素样蛋白。 在一个实施方案中,与天然存在的人干扰素α2b(HuIFN-α2b)相比,描述了通过基因改组技术产生的重组蛋白质具有增强的抗病毒和抗增殖活性。 本发明包括编码蛋白质的多核苷酸和包含多核苷酸的重组载体和宿主细胞。 优选地,多核苷酸选自各自具有与SEQ ID:No.1至少93%相同的序列的多核苷酸,并且所述蛋白质选自蛋白质组,其各自具有与SEQ ID NO:至少85%相同的氨基酸序列 否:2.包含蛋白质的蛋白质和组合物可用于治疗对干扰素治疗(例如病毒性疾病和癌症)有反应的病症。

    ENTITY-BASED BUSINESS INTELLIGENCE
    10.
    发明申请
    ENTITY-BASED BUSINESS INTELLIGENCE 有权
    基于实体的业务智能

    公开(公告)号:US20090006349A1

    公开(公告)日:2009-01-01

    申请号:US12133552

    申请日:2008-06-05

    IPC分类号: G06F7/06 G06F17/30

    CPC分类号: G06F17/30592 G06F17/30489

    摘要: A method is disclosed for conducting a query to transform data in a pre-existing database, the method comprising: collecting database information from the pre-existing database, the database information including inconsistent dimensional tables and fact tables; running an entity discovery process on the inconsistent dimensional tables and the fact tables to produce entity mapping tables; using the entity mapping tables to resolve the inconsistent dimensional tables into resolved dimensional tables; and running the query on a resolved database to obtain a query result, the resolved database including the resolved dimensional table.

    摘要翻译: 公开了一种用于进行在预先存在的数据库中转换数据的查询的方法,所述方法包括:从预先存在的数据库收集数据库信息,所述数据库信息包括不一致的维度表和事实表; 对不一致的维度表和事实表运行实体发现过程以生成实体映射表; 使用实体映射表将不一致的维度表解析为已解析的维度表; 并在解析的数据库上运行查询以获取查询结果,解析的数据库包括已解析的维度表。